We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

65 hedge funds and large institutions have $509M invested in Q32 Bio in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

30% more funds holding

Funds holding: 50 → 65 (+15)

12% more capital invested

Capital invested by funds: $455M → $509M (+$53M)

0.4% more ownership

Funds ownership: 2.97% → 3.37% (+0.4%)

Holders
65
Holders Change
+15
Holders Change %
+30%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
19
Increased
23
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$25.2M
2
BlackRock
BlackRock
New York
+$17.6M
3
State Street
State Street
Massachusetts
+$2.63M
4
PC
Polar Capital
United Kingdom
+$2.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.6M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.08M
2
MC
Maverick Capital
Texas
-$3.8M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$3.28M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$2.06M
5
SFM
Sphera Funds Management
Israel
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$117M – – –
Temasek Holdings
2
Temasek Holdings
Singapore
$72M – – –
JP Morgan Chase
3
JP Morgan Chase
New York
$49.8M -$466K -1,231 -1%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$47.2M -$5.08M -13,426 -10%
RI
5
RTW Investments
New York
$36.5M +$25.2M +66,588 +276%
BlackRock
6
BlackRock
New York
$32.7M +$17.6M +46,505 +134%
VC
7
Vivo Capital
California
$25.9M – – –
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$21.7M +$2.65K +7 +0%
VM
9
VV Manager
Massachusetts
$17.2M +$16.2M +42,825 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$12.3M +$1.6M +4,230 +16%
RSCM
11
Rock Springs Capital Management
Maryland
$10.1M -$420K -1,111 -4%
Franklin Resources
12
Franklin Resources
California
$9.25M +$419K +1,107 +5%
CC
13
Casdin Capital
New York
$7.83M – – –
Lord, Abbett & Co
14
Lord, Abbett & Co
New Jersey
$6.21M -$2.06M -5,440 -26%
State Street
15
State Street
Massachusetts
$6.13M +$2.63M +6,948 +84%
Northern Trust
16
Northern Trust
Illinois
$4.05M +$1.26M +3,343 +50%
SFM
17
Sphera Funds Management
Israel
$3.6M -$1.77M -4,673 -34%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$3.42M +$882K +2,332 +38%
GTP
19
Global Thematic Partners
New York
$3.01M – – –
AG
20
Artal Group
Luxembourg
$2.24M – – –
PC
21
Polar Capital
United Kingdom
$2.24M +$2.1M +5,556 New
Victory Capital Management
22
Victory Capital Management
Texas
$1.93M -$31.4K -83 -2%
Charles Schwab
23
Charles Schwab
California
$1.49M +$257K +679 +22%
Ameriprise
24
Ameriprise
Minnesota
$1.33M +$1.25M +3,295 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.31M +$655K +1,733 +114%
1
2 3

QTTB Hedge Fund Activity: Q4 2018 in Review

65 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2018, worth a combined $509M — up 12% from $455M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new QTTB positions and 4 closed out — a net gain of 15 holders — while 23 added to existing stakes and 12 trimmed.

The largest buyer was RTW Investments, adding an estimated $25.2M. The largest seller was Fidelity Investments, cutting an estimated $5.08M.

  • 65 institutional investors held Q32 Bio (QTTB) as of Q4 2018, up from 50 in Q3 2018.
  • Funds reported $509M of Q32 Bio stock for Q4 2018, up 12% quarter-over-quarter.
  • 19 funds opened new Q32 Bio positions in Q4 2018 and 4 closed out, a net change of +15 holders.
  • The largest Q32 Bio buyer in Q4 2018 was RTW Investments, an estimated $25.2M added.
  • The largest Q32 Bio seller in Q4 2018 was Fidelity Investments, an estimated $5.08M sold.

Based on aggregated 13F filings for Q4 2018.